Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MDRX logo MDRX
Upturn stock ratingUpturn stock rating
MDRX logo

Veradigm Inc. (MDRX)

Upturn stock ratingUpturn stock rating
$4.93
Last Close (24-hour delay)
Profit since last BUY7.17%
upturn advisory
Consider higher Upturn Star rating
BUY since 44 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: MDRX (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

3 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $5.83

1 Year Target Price $5.83

Analysts Price Target For last 52 week
$5.83 Target price
52w Low $3
Current$4.93
52w High $11.8

Analysis of Past Performance

Type Stock
Historic Profit -5.31%
Avg. Invested days 49
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 535.40M USD
Price to earnings Ratio -
1Y Target Price 5.83
Price to earnings Ratio -
1Y Target Price 5.83
Volume (30-day avg) 3
Beta 0.69
52 Weeks Range 3.00 - 11.80
Updated Date 08/29/2025
52 Weeks Range 3.00 - 11.80
Updated Date 08/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.18

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-26
When -
Estimate 0.07
Actual -

Profitability

Profit Margin -14.7%
Operating Margin (TTM) 16.59%

Management Effectiveness

Return on Assets (TTM) -0.62%
Return on Equity (TTM) -1.69%

Valuation

Trailing PE -
Forward PE 15.17
Enterprise Value 308248000
Price to Sales(TTM) 0.91
Enterprise Value 308248000
Price to Sales(TTM) 0.91
Enterprise Value to Revenue 0.52
Enterprise Value to EBITDA 5.28
Shares Outstanding 108600000
Shares Floating 80919355
Shares Outstanding 108600000
Shares Floating 80919355
Percent Insiders 3.75
Percent Institutions 41.94

ai summary icon Upturn AI SWOT

Veradigm Inc.

stock logo

Company Overview

overview logo History and Background

Veradigm Inc., formerly known as Allscripts Healthcare Solutions, was founded in 1986. It has evolved through acquisitions and strategic partnerships to become a leading provider of healthcare information technology solutions. A significant milestone was the acquisition of Misys Healthcare Systems in 2008. The company rebranded to Veradigm in 2018 to reflect its focus on data-driven insights and connectivity.

business area logo Core Business Areas

  • Payer Connectivity: Provides solutions for payer enrollment, credentialing, and other administrative tasks.
  • Clinical Solutions: Offers electronic health record (EHR) systems, practice management software, and e-prescribing tools for healthcare providers.
  • Data and Analytics: Provides healthcare data and analytics solutions to improve clinical decision-making, population health management, and research.
  • Research Solutions: Offers access to aggregated patient data for pharmaceutical and biotech companies and research institutions.

leadership logo Leadership and Structure

The leadership team includes the CEO, CFO, CTO, and other senior executives. The organizational structure is based on functional departments and business units focused on specific product lines and customer segments.

Top Products and Market Share

overview logo Key Offerings

  • Sunrise EHR: A comprehensive EHR system for hospitals and large healthcare organizations. While specific market share data is difficult to pinpoint, it is a significant player in the enterprise EHR market. Competitors include Epic Systems, Cerner, and Meditech.
  • Professional EHR: An EHR solution designed for smaller practices and ambulatory care settings. Competitors include athenahealth, eClinicalWorks, and NextGen Healthcare. Revenue generated from this product line constitutes a substantial portion of Veradigm's clinical segment revenue.
  • Veradigm Network: A data and connectivity platform that enables data exchange between payers, providers, and other healthcare stakeholders. Competitors include Change Healthcare (now part of Optum), and Inovalon.

Market Dynamics

industry overview logo Industry Overview

The healthcare IT industry is experiencing growth driven by the increasing adoption of EHRs, the shift towards value-based care, and the growing demand for data analytics and interoperability. Consolidation within the industry is ongoing.

Positioning

Veradigm Inc. is positioned as a leading provider of healthcare IT solutions and data analytics. Its competitive advantages include its extensive network of providers, its comprehensive suite of products, and its expertise in data management and analytics.

Total Addressable Market (TAM)

The total addressable market for healthcare IT is estimated to be in the hundreds of billions of dollars. Veradigm is positioned to capture a portion of this market through its various solutions across provider, payer, and life science segments.

Upturn SWOT Analysis

Strengths

  • Established customer base
  • Comprehensive product portfolio
  • Strong data analytics capabilities
  • Extensive network connectivity

Weaknesses

  • Debt from prior acquisitions
  • Integration challenges from past mergers
  • Dependence on regulatory changes
  • Complex organizational structure

Opportunities

  • Expanding into new markets (e.g., telehealth)
  • Developing new data analytics solutions
  • Acquiring complementary technologies
  • Partnering with other healthcare organizations

Threats

  • Increasing competition
  • Cybersecurity risks
  • Regulatory changes
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • EPIC
  • ATHA
  • CERN
  • DXCM

Competitive Landscape

Veradigm Inc. competes with large, established healthcare IT vendors as well as smaller, niche players. It must differentiate itself through product innovation, customer service, and data analytics capabilities.

Major Acquisitions

Transaction Data Systems (TDS)

  • Year: 2017
  • Acquisition Price (USD millions): 235
  • Strategic Rationale: Expanded Veradigm's pharmacy solutions and enhanced its connectivity to the pharmacy market.

Growth Trajectory and Initiatives

Historical Growth: Veradigm has experienced growth through acquisitions and organic initiatives, but it has also faced challenges related to integration and market competition.

Future Projections: Analyst estimates vary, but generally project moderate revenue growth driven by demand for healthcare IT solutions and data analytics.

Recent Initiatives: Recent initiatives include developing new cloud-based solutions, expanding its data analytics offerings, and partnering with other healthcare organizations.

Summary

Veradigm is a significant player in healthcare IT, offering diverse clinical and data solutions. Its strengths lie in its established network and data analytics. However, debt and competition pose ongoing challenges, requiring strategic initiatives to bolster growth and market position. Successful expansion into new areas, coupled with efficient integration of acquired assets, will be key to sustained success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Market Research Reports
  • Analyst Reports

Disclaimers:

This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance are subject to change. Verify all information independently before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Veradigm Inc.

Exchange NASDAQ
Headquaters Chicago, IL, United States
IPO Launch date 1999-07-26
CEO -
Sector Healthcare
Industry Health Information Services
Full time employees 2450
Full time employees 2450

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.